UnThreaded | Threaded | Whole Thread (1) | Ignore Thread Prev Thread | Prev | Next | Next Thread
Author: jimpiccard Big red star, 1000 posts Old School Fool Add to my Favorite Fools Ignore this person (you won't see their posts anymore) Number: of 3435  
Subject: AOBO Date: 8/9/2003 2:15 AM
Post New | Post Reply | Reply Later | Create Poll Report this Post | Recommend it!
Recommendations: 1
just fyi: AOBO/Amerian Bioengineering CEO interview now posted on CEOcast.com. (can require free registration to listen to).
"American Oriental Bioengineering, Inc. is a leading Chinese nutracuetical company that uses proprietary processes for producing soybean protein peptide more efficiently than traditional extracting techniques. These techniques are used to manufacture and formulate supplemental and medicinal products. Soybean peptides are used widely in general food, health food products, medicines and etc. The Company sees significant opportunities for the marketing of these soybean products and many of their other bioengineer products.".

Note: I find CEOcast.com very useful--in spite of the fact that they are compensated by the companies that they cover. They basically serve as a brief, phone-interview-of-the-CEO introduction to a (usually very small) company. Same interview format for each company interviewed......they have to, since they do several a day. But this tends to keep it short and no-nonsense or hype.
This was the first interview I've listened to that was interpreted (i.e, the CEO was speaking in Chinese from China). Thus, it takes longer than 'necessary' for those of us who don't speak Chinese. However, for those who do, you hear the actual CEO un-edited, which I would think is always a plus in trying to gauge his measure. (I also wouldn't mind at all if any native Chinese speaker would post a word or two about whether they picked up anything in his interview that the interpreter didn't pass on; it often happens!!)

Currently soybean protein production is not their primary revenue driver; but they expect that to start changing by the end of 2003. Their emphasis seems to be to apply modern extraction and production techniques in order to make traditional (and increasingly non-traditional) Chinese therapeutics.

also, a PR from last week:
"Press Release Source: American Oriental Bioengineering Inc.

AOBO Predicts Record Second Quarter and Half Year Profit Growth
Wednesday July 30, 12:00 pm ET

HONG KONG, July 30 /PRNewswire-FirstCall/ -- American Oriental Bioengineering Inc. (OTC Bulletin Board: AOBO - News; the 'Company') today announces that the Company projects a record second quarter and half year profit growth in its forth coming second quarter result announcement.

ADVERTISEMENT
Shujun Liu, Chairman and CEO of the Company stated, "The soybean protein peptide products acquired at the beginning of this year has contributed significant revenue and profit growth for the Company. Together with the sales growth of our existing products, we predict a record second quarter and half year profit growth. Looking forward, we will focus on penetrating our existing products and soybean protein peptide products into new overseas markets to sustain continuous Company growth"

About American Oriental Bioengineering, Inc.

AOBO is a leading Chinese nutracuetical company that uses proprietary processes for producing soybean protein peptide more efficiently than traditional extracting techniques. These techniques are used to manufacture and formulate supplemental and medicinal products. Soybean peptides are used widely in general food, health food products, medicines and etc. The Company sees significant opportunities for the marketing of these soybean products and many of their other bioengineer products.

Safe Harbor Statement

Except for the historical statements made herein, the statements made in this release are forward-looking statements, including. Risk factors that could cause actual results to differ materially from those projected in forward-looking statements include, but are not limited to, general business conditions, managing growth, and political and other business risks. All forward-looking statements are expressly qualified in their entirety by this Cautionary Statement and the risks and other factors detailed in the Company's reports filed with the Securities and Exchange Commission.


Source: American Oriental Bioengineering Inc.

AOBO.OB 1.90 0.00

JP
Post New | Post Reply | Reply Later | Create Poll Report this Post | Recommend it!
Print the post  
UnThreaded | Threaded | Whole Thread (1) | Ignore Thread Prev Thread | Prev | Next | Next Thread

Announcements

Foolanthropy 2014!
By working with young, first-time moms, Nurse-Family Partnership is able to truly change lives – for generations to come.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Post of the Day:
Macro Economics

Economic Implications of Cuba
What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
Community Home
Speak Your Mind, Start Your Blog, Rate Your Stocks

Community Team Fools - who are those TMF's?
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and "#1 Media Company to Work For" (BusinessInsider 2011)! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.
Advertisement